Stockreport

MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study [Yahoo! Finance]

MeiraGTx Holdings plc - Ordinary Shares  (MGTX) 
PDF MeiraGTx Holdings ' MGTX clinical bridging study of its gene therapy candidate, AAV-GAD, for treating Parkinson's disease (PD) met its primary study objective of safety [Read more]